Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction. Krittayaphong R, Permsuwan U. Int J Cardiol 2020 Aug 13. pii: S0167-5273(20)33544.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Krittayaphong R, Permsuwan U. Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction. Int J Cardiol 2020 Aug 13. pii: S0167-5273(20)33544.
PMID: 32800910